Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (181-190 of 259) with videos related to

Pageof 26
Sort By:
Virology|October 15, 1978
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virusP J Fischinger, A E Frankel, J H Elder, et al.
Blood|September 6, 2001
Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSFA Senchenkov, T Y Han, H Wang, et al.
Journal of Biological Response Modifiers|February 1, 1988
A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemiaA A Hertler, D M Schlossman, M J Borowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemiaArthur E Frankel, Donald R Fleming, Philip D Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude miceTie Fu Liu, Philip D Hall, Kimberley A Cohen, et al.
Protein Expression and Purification|May 25, 1999
High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trialsA E Frankel, J Ramage, A Latimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
RLIP76 and CancerSanjay Awasthi, Sharad S Singhal, Yogesh C Awasthi, et al.
Hybridoma (2005)|April 19, 2012
Anti-caveolin-1 antibodies as anti-prostate cancer therapeuticsShu-Ru Kuo, Salahaldin A Tahir, Sanghee Park, et al.
Experimental Hematology|November 9, 2002
Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion proteinArthur E Frankel, Miloslav Beran, Donna E Hogge, et al.
Haematologica|March 22, 2015
Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphomaArthur E Frankel, Jung H Woo, Chul Ahn, et al.
Pageof 26

Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
Virology|October 15, 1978
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virusP J Fischinger, A E Frankel, J H Elder, et al.
Blood|September 6, 2001
Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSFA Senchenkov, T Y Han, H Wang, et al.
Journal of Biological Response Modifiers|February 1, 1988
A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemiaA A Hertler, D M Schlossman, M J Borowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemiaArthur E Frankel, Donald R Fleming, Philip D Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude miceTie Fu Liu, Philip D Hall, Kimberley A Cohen, et al.
Protein Expression and Purification|May 25, 1999
High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trialsA E Frankel, J Ramage, A Latimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
RLIP76 and CancerSanjay Awasthi, Sharad S Singhal, Yogesh C Awasthi, et al.
Hybridoma (2005)|April 19, 2012
Anti-caveolin-1 antibodies as anti-prostate cancer therapeuticsShu-Ru Kuo, Salahaldin A Tahir, Sanghee Park, et al.
Experimental Hematology|November 9, 2002
Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion proteinArthur E Frankel, Miloslav Beran, Donna E Hogge, et al.
Haematologica|March 22, 2015
Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphomaArthur E Frankel, Jung H Woo, Chul Ahn, et al.
Pageof 26